Outlook Therapeutics (OTLK) Receivables - Other (2015 - 2016)
Outlook Therapeutics' Receivables - Other was $43,350 in fiscal Q3 2016 (quarter ended Jun 30, 2016), up 0.4% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Receivables - Other (2015 - 2016) Analysis & Trends
At the end of FY2015 (ended Sep 30, 2015), Receivables - Other at Outlook Therapeutics came in at $117,506.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 43,350.00 |
| Mar 31, 2016 | 43,187.00 |
| Sep 30, 2015 | 117,506.00 |
API Access
Outlook Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();